Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Taurus Flexi Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹95.96 |
| 12 Apr 2015 | ₹151.32 |
| 31 May 2016 | ₹138.73 |
| 19 Jul 2017 | ₹176.88 |
| 07 Sep 2018 | ₹188.68 |
| 27 Oct 2019 | ₹173.95 |
| 15 Dec 2020 | ₹186.96 |
| 03 Feb 2022 | ₹243.12 |
| 25 Mar 2023 | ₹224.47 |
| 12 May 2024 | ₹333.35 |
| 01 Jul 2025 | ₹368.30 |
| 20 Aug 2026 | ₹381.62 |
| Metric | Taurus · Direct NAV ₹246.45 Very High risk ★☆☆☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| +5.17% | +4.32% | |
| +12.78% | +14.11% | |
| +11.28% | +12.53% | |
| +9.70% | +13.78% | |
| +10.33% | +14.48% | |
| +10.62% | — | |
| +10.97% | +16.56% | |
| +10.22% | +15.80% | |
| +10.56% | +15.46% | |
| Risk | ||
| 14.78% | 14.19% | |
| 0.42 | 0.53 | |
| 0.58 | 0.73 | |
| -40.99% | -30.01% | |
| Nifty 500 | — | |
| +0.24% | +2.15% | |
| 1.02 | 0.97 | |
| 104.0% | 102.4% | |
| 105.1% | 90.2% | |
| 2.70% | 0.96% | |
| ₹335.94Cr | ₹4,325Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 99% | 34% | |
| Anuj Kapil · 3.2y | — | |
| 02 Jan 2013 | — | |
| 40 | — | |
| 47.4% | — | |
| 3.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.